SARABJIT KAUR: Open Payments
NPI 1649980939 · MURRIETA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 16 payments from 7 companies in 2025. Trend: 2023 $249 · 2024 $792 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $135 |
| PFIZER INC. | 3 | $73 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Corcept Therapeutics | 1 | $18 |
Products named: REXULTI, PREVNAR 20, ELIQUIS, Wegovy, BREZTRI, Kerendia, Ozempic, JARDIANCE.
Industry payments across CA — which companies pay providers there.
